Literature DB >> 300627

Aprotinin and growth of Walker 256 carcinosarcoma in the rat.

A W Thomson, R G Pugh-Humphreys, C H Horne, D J Tweedle.   

Abstract

Growth of the Walker 256 carcinosarcoma implanted within various sites in Spraque-Dawley rats was investigated in animals receiving twice daily i.p. injections of the antiprotease aprotinin. Although administration of aprotinin partially attenuated the growth and lethality of i.p. tumour, no effect of aprotinin was found on intramuscular tumour development. Furthermore, we were unable to demonstrate unequivocal growth inhibition by aprotinin of lung tumour colonies from i.v. injection of tumour cells. Histological examination of intramuscular and pulmonary tumours revealed little evidence of host cellular immune response in either saline- or aprotinin-treated rats.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300627      PMCID: PMC2025359          DOI: 10.1038/bjc.1977.68

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES.

Authors:  E E CLIFFTON; D AGOSTINO
Journal:  J Natl Cancer Inst       Date:  1964-11       Impact factor: 13.506

2.  Effect on tumor homografts of treating hosts with antiproteolytic enzyme compounds.

Authors:  R W GILLETTE; A FINDLEY; H CONWAY
Journal:  Proc Soc Exp Biol Med       Date:  1963-04

3.  Release of fibrinolytic activators from human tumours cultured in vitro.

Authors:  G Björlin; M Pandolfi; B Astedt
Journal:  Experientia       Date:  1972-07-15

4.  Fluorescent-labelled aprotinin: a new reagent for the histochemical detection of acid mucosubstances.

Authors:  J A Kiernan; R W Stoddart
Journal:  Histochemie       Date:  1973

Review 5.  Fibrinolysin system and vasoactive kinins.

Authors:  N Back
Journal:  Fed Proc       Date:  1966 Jan-Feb

6.  Proteolytic enzymes initiating cell division and escape from contact inhibition of growth.

Authors:  M M Burger
Journal:  Nature       Date:  1970-07-11       Impact factor: 49.962

7.  Release from density dependent growth inhibition by proteolytic enzymes.

Authors:  B M Sefton; H Rubin
Journal:  Nature       Date:  1970-08-22       Impact factor: 49.962

8.  Collagenolytic enzymes in human neoplasms.

Authors:  M H Dresden; S A Heilman; J D Schmidt
Journal:  Cancer Res       Date:  1972-05       Impact factor: 12.701

9.  Inflammatory changes in tumour vessels after systemic 5-hydroxytryptamine, bradykinin, kallikrein, or lysolecithin.

Authors:  D B Cater; C R Taylor
Journal:  Br J Cancer       Date:  1966-09       Impact factor: 7.640

10.  Inhibition of malignant cell invasion in vitro by a proteinase inhibitor.

Authors:  A L Latner; E Longstaff; K Pradhan
Journal:  Br J Cancer       Date:  1973-06       Impact factor: 7.640

View more
  3 in total

1.  On the prevention of haematogenous tumor metastases rats. The role of the proteinase inhibitor "Trasylol".

Authors:  R Stein-Werblowsky
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

Review 2.  Adhesion molecules and their role in cancer metastasis.

Authors:  R M Lafrenie; M R Buchanan; F W Orr
Journal:  Cell Biophys       Date:  1993 Aug-Dec

3.  Endocytosis of the antiprotease aprotinin by Landschütz ascites carcinoma cells and its effects in vitro and in vivo.

Authors:  A W Thomson; D J Tweedie; R G Pugh-Humphreys; M Arthur
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.